Free Trial
OTCMKTS:HKMPF

Hikma Pharmaceuticals (HKMPF) Stock Price, News & Analysis

Hikma Pharmaceuticals logo
$27.73 0.00 (0.00%)
As of 06/20/2025

About Hikma Pharmaceuticals Stock (OTCMKTS:HKMPF)

Key Stats

Today's Range
$27.73
$27.73
50-Day Range
$26.20
$27.73
52-Week Range
$22.56
$28.92
Volume
N/A
Average Volume
100 shs
Market Capitalization
$6.15 billion
P/E Ratio
N/A
Dividend Yield
3.46%
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Receive HKMPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

HKMPF Stock News Headlines

Chaotic markets? No worries!
As you may have seen over the last few weeks, I've been giving out special daily setups on my favorite ticker. We’ve been taking these setups @ 10AM and so far, we've posted 28 different payouts … Each of which were delivered at exactly 4PM as the market closed. You see, these setups require zero oversight and have shown the power to deliver in the most chaotic market conditions. And after a few weeks of fine-tuning … I knew it was time to let you in on The 4 PM Payout Plan. That's why Jack Carter and I pulled back the curtain to reveal how we've been able to nail in a 96% win rate in the same window the market lost 11 trillion dollars in value.
See More Headlines

HKMPF Stock Analysis - Frequently Asked Questions

Hikma Pharmaceuticals' stock was trading at $24.12 on January 1st, 2025. Since then, HKMPF stock has increased by 15.0% and is now trading at $27.7301.
View the best growth stocks for 2025 here
.

Shares of HKMPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Record date for 5/1 Dividend
3/21/2025
Ex-Dividend for 5/1 Dividend
3/21/2025
Dividend Payable
5/01/2025
Today
6/23/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:HKMPF
Previous Symbol
OTC:HKMPF
CIK
N/A
Employees
9,500
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.13 billion
Cash Flow
$2.23 per share
Price / Cash Flow
12.43
Book Value
$10.46 per share
Price / Book
2.65

Miscellaneous

Free Float
N/A
Market Cap
$6.15 billion
Optionable
Not Optionable
Beta
0.57

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:HKMPF) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners